STERIS Announces Financial Results for Fiscal 2022 Fourth Quarter and Full Year
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
STERIS (STE) PT Lowered to $248 at Needham & Company
May 12, 2022 12:46 PM EDTNeedham & Company analyst Mike Matson lowered the price target on STERIS (NYSE: STE) to $248.00 (from $263.00) while maintaining a Buy rating following earnings.
The analyst commented, "STE's F4Q22 revenue and EPS beat consensus. Organic revenue growth improved from the prior quarter overall and in all... More
Steris (STE) Tops Q4 EPS by 2c
May 11, 2022 4:34 PM EDTSteris (NYSE: STE) reported Q4 EPS of $2.04, $0.02 better than the analyst estimate of $2.02. Revenue for the quarter came in at $1.2 billion versus the consensus estimate of $1.19 billion.
GUIDANCE:
Steris sees FY2023 EPS of $8.55-$8.75, versus the consensus of $7.91.
For earnings history and earnings-related data on Steris (STE) click here.
... More